AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2021
Sep 3, 2021
30786_dirs_2021-09-03_b81409d6-f032-4569-a244-93bf73841f65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-09-01
Reporting Person: Daskal Ilan (EVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-02 | Bio-Rad A Common Stock | M | 540 | $524.30 | Acquired | 547 | Direct |
| 2021-09-02 | Bio-Rad A Common Stock | S | 440 | $828.00 | Disposed | 107 | Direct |
| 2021-09-02 | Bio-Rad A Common Stock | S | 100 | $828.01 | Disposed | 7 | Direct |
| 2021-09-02 | Bio-Rad A Common Stock | M | 541 | — | Acquired | 548 | Direct |
| 2021-09-02 | Bio-Rad A Common Stock | F | 269 | $825.77 | Disposed | 279 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-01 | Restricted Stock Units | $0 | A | 1823 | Acquired | Bio-Rad A Common Stock (1823) | Direct | |
| 2021-09-01 | Non-Qualified Stock Option (right to buy) | $814.95 | A | 1823 | Acquired | 2031-09-01 | Bio-Rad A Common Stock (1823) | Direct |
| 2021-09-02 | Non-Qualified Stock Option (right to buy) | $524.30 | M | 540 | Disposed | 2030-09-02 | Bio-Rad A Common Stock (540) | Direct |
| 2021-09-02 | Restricted Stock Units | $0 | M | 541 | Disposed | Bio-Rad A Common Stock (541) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F4: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
F5: The option, representing a right to purchase a total of 2,166 shares, became exercisable in four equal annual installments beginning on September 2, 2021, which was the first anniversary of the date on which the option was granted.
F6: On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.